Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Luqiang Wang"'
Autor:
Lutian Yao, Jiawei Lu, Leilei Zhong, Yulong Wei, Tao Gui, Luqiang Wang, Jaimo Ahn, Joel D Boerckel, Danielle Rux, Christina Mundy, Ling Qin, Maurizio Pacifici
Publikováno v:
eLife, Vol 12 (2023)
Insufficient bone fracture repair represents a major clinical and societal burden and novel strategies are needed to address it. Our data reveal that the transforming growth factor-β superfamily member Activin A became very abundant during mouse and
Externí odkaz:
https://doaj.org/article/e2afbc82a06e4e92a58094be629da842
Autor:
Paolo F. Caimi, Weiyun Z. Ai, Juan Pablo Alderuccio, Kirit M. Ardeshna, Mehdi Hamadani, Brian Hess, Brad S. Kahl, John Radford, Melhem Solh, Anastasios Stathis, Pier Luigi Zinzani, Ying Wang, Yajuan Qin, Luqiang Wang, Zhiying Cindy Xu, Carmelo Carlo-Stella
Publikováno v:
Haematologica, Vol 109, Iss 4 (2023)
Therapies that demonstrate durable, long-term responses with manageable safety and tolerability are needed for patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL). Loncastuximab tesirine (loncastuximab tesirine-lpyl [Lonca]),
Externí odkaz:
https://doaj.org/article/bd44e81cc44e4e969307a93b7e55be0c
Autor:
Paolo F Caimi, Weiyun Z Ai, Juan Pablo Alderuccio, Kirit M Ardeshna, Mehdi Hamadani, Brian Hess, Brad S Kahl, John Radford, Melhem Solh, Anastasios Stathis, Pier Luigi Zinzani, Ying Wang, Yajuan Qin, Luqiang Wang, Cindy Xu, Carmelo Carlo-Stella
Publikováno v:
HemaSphere, Vol 7, p e402511c (2023)
Externí odkaz:
https://doaj.org/article/979bb44e11154e29b5cffd1614fbdd2a
Autor:
Luqiang Wang, Ming Lu, Xinxin Zhang, Zhenguo Zhao, Xiaoyang Li, Ting Liu, Libin Xu, Shengji Yu
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectivePulmonary cement embolism is a rare but underestimated complication of vertebroplasty due to the relative lack of study and examination. This study aims to investigate the incidence of pulmonary cement embolism in patients with spinal metast
Externí odkaz:
https://doaj.org/article/6627018dcb2b444fb9d88016c58c0897
Autor:
Lutian Yao, Jiawei Lu, Leilei Zhong, Yulong Wei, Tao Gui, Luqiang Wang, Ahn, Jaimo, Boerckel, Joel D., Rux, Danielle, Mundy, Christina, Ling Qin, Pacifici, Maurizio
Publikováno v:
eLife; 1/11/2024, p1-26, 26p
Autor:
Leilei Zhong, Lutian Yao, Robert J Tower, Yulong Wei, Zhen Miao, Jihwan Park, Rojesh Shrestha, Luqiang Wang, Wei Yu, Nicholas Holdreith, Xiaobin Huang, Yejia Zhang, Wei Tong, Yanqing Gong, Jaimo Ahn, Katalin Susztak, Nathanial Dyment, Mingyao Li, Fanxin Long, Chider Chen, Patrick Seale, Ling Qin
Publikováno v:
eLife, Vol 9 (2020)
Bone marrow mesenchymal lineage cells are a heterogeneous cell population involved in bone homeostasis and diseases such as osteoporosis. While it is long postulated that they originate from mesenchymal stem cells, the true identity of progenitors an
Externí odkaz:
https://doaj.org/article/e1bde3bf4480496eb8cd45466e510294
Publikováno v:
Inflammation Research. 71:205-214
This study aimed to investigate the relationship between miR-21 and lipopolysaccharide (LPS)-induced myocardial injury and its molecular and regulatory mechanisms.We constructed LPS-mediated myocardial injury model using C57BL/6J mice and H9c2 cells.
Autor:
Wei‐Ju Tseng, Wonsae Lee, Hongbo Zhao, Yang Liu, Wenzheng Wang, Chantal MJ Bakker, Yihan Li, Carlos Osuna, Wei Tong, Luqiang Wang, Xiaoyuan Ma, Ling Qin, X Sherry Liu
Publikováno v:
J Bone Miner Res
Despite the potent effect of intermittent parathyroid hormone (PTH) treatment on promoting new bone formation, bone mineral density (BMD) rapidly decreases upon discontinuation of PTH administration. To uncover the mechanisms behind this adverse phen
Autor:
Lutian Yao, Leilei Zhong, Yulong Wei, Tao Gui, Luqiang Wang, Jaimo Ahn, Joel Boerckel, Danielle Rux, Christina Mundy, Ling Qin, Maurizio Pacifici
Insufficient bone fracture repair represents a significant clinical burden, and identification of novel therapeutics enhancing repair would have substantial clinical and societal impact. Activin A is a TGF-β protein superfamily member known to stimu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::241b0a7011a6a3df475b8609833927e5
https://doi.org/10.1101/2022.10.05.510962
https://doi.org/10.1101/2022.10.05.510962
Autor:
Melhem Solh, Karin Havenith, Jay Feingold, Brad S. Kahl, Erin Reid, Luqiang Wang, Carmelo Carlo-Stella, Leonard T. Heffner, John Radford, Owen A. O'Connor, Paolo Caimi, William Townsend, Joseph Boni, Kirit M. Ardeshna, David Ungar, Yajuan Gu Qin, Mehdi Hamadani
Publikováno v:
Blood
Hamadani, M, Radford, J, Carlo-Stella, C, Caimi, P F, Reid, E G, O'Connor, O A, Feingold, J, Ardeshna, K M, Townsend, W M, Solh, M, Heffner, L T, Ungar, D, Wang, L, Boni, J P, Havenith, K, Qin, Y G & Kahl, B 2021, ' Final Results of a Phase 1 Study of Loncastuximab Tesirine in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma ', Blood, vol. 137, no. 19, pp. 2634-2645 . https://doi.org/10.1182/blood.2020007512
Hamadani, M, Radford, J, Carlo-Stella, C, Caimi, P F, Reid, E G, O'Connor, O A, Feingold, J, Ardeshna, K M, Townsend, W M, Solh, M, Heffner, L T, Ungar, D, Wang, L, Boni, J P, Havenith, K, Qin, Y G & Kahl, B 2021, ' Final Results of a Phase 1 Study of Loncastuximab Tesirine in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma ', Blood, vol. 137, no. 19, pp. 2634-2645 . https://doi.org/10.1182/blood.2020007512
The prognosis for patients with relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL) remains poor, with a need for alternatives to current salvage therapies. Loncastuximab tesirine (ADCT-402) is an antibody-drug conjugate comprising a hum